Teva launches generic ADHD drug in US
TEVA | Quote | Chart | News | PowerRating -- Teva Pharmaceutical Industries, a generic pharmaceutical company, has commenced commercial shipment of its generic version of Shire Pharmaceuticals's Adderall XR capsules, 5mg, 10mg, 15mg, 20mg, 25mg and 30mg.
Teva's generic Adderall XR capsules are indicated for the treatment of attention deficit hyperactivity disorder (ADHD).
In August 2006, Teva's subsidiary Barr Pharmaceuticals entered into a licensing agreement with Shire as part of a settlement of patent litigation between the parties. Under this agreement, Shire granted the company the exclusive right to sell a generic version of Adderall XR capsules for 180 days from the date of commercial launch.
http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall
not be liable for errors or delays in the content, or for any actions
taken in reliance thereon
For full details on Teva Pharm Ind (TEVA) TEVA. Teva Pharm Ind (TEVA) has Short Term PowerRatings at TradingMarkets. Details on Teva Pharm Ind (TEVA) Short Term PowerRatings is available at This Link.
For full details on Shire Pharma Grp Plc Ads (SHPGY) SHPGY. Shire Pharma Grp Plc Ads (SHPGY) has Short Term PowerRatings at TradingMarkets. Details on Shire Pharma Grp Plc Ads (SHPGY) Short Term PowerRatings is available at This Link.
- Uptrend Spotted in Shares of Shire (SHPGY) - 02/09/10
- Israeli Teva gets rights for multiple sclerosis drug in Nordic, Baltic states - 02/09/10
- Teva Pharmaceutical Industries: The Trend Continues Higher (TEVA) - 02/09/10
- BiomedReports: News and FDA Updates for Synta (NASDAQ:SNTA), Teva (NASDAQ:TEVA), Active Biotech (NASDAQ:ACTI) - 02/09/10
- Teva and Active Biotech amend marketing and distribution agreement - 02/09/10
- More News >>


